8 Commercial Considerations for Tumor-Agnostic Therapies
The tumor-agnostic space is incredibly exciting and an area that is likely to be explored further. To realize the benefits of these new therapies and facilitate patient access to tumor-agnostic therapies, manufacturers will need to take several actions to ensure uptake and encourage ongoing innovation in the relevant cancers.
Before tumor-agnostic products may be considered as a serious treatment option for oncology patients, manufacturers will need to continue with robust research and development, educating stakeholders, and building confidence among providers.
Follow this link to read the full blog post – Tumor-Agnostic Therapies: The Complex Path to Commercial Viability.